Expert Urologist and Men’s Health Specialist in Sydney

Meet Dr Ross

Dr Ross Calopedos is a Sydney-based urologist dedicated to improving health through a multidisciplinary and patient-focused approach.

His practice spans the full spectrum of urology, with a specialised focus on sexual medicine, erectile dysfunction, Peyronie’s disease and prostate cancer survivorship. Dr Ross also provides advanced solutions for benign prostate conditions, renal stone management and other urological concerns, combining cutting-edge techniques with compassionate care.

A Passion for Sexual Medicine

Dr Ross is passionate about breaking down the stigma surrounding erectile dysfunction and other male sexual health issues. Recognising a lack of infrastructure to adequately address these conditions in Australia, he sought advanced international training to bridge this gap.

His global fellowship experience includes mentorship under world-renowned experts such as: Dr Paul Perito, Professor David Ralph, Professor Koenraad van Renterghem and Dr Juan I. Martínez-Salamanca.

This training has equipped Dr Ross with unparalleled expertise in minimally-invasive treatment of erectile dysfunction positioning him as Sydney’s penile implant surgery specialist.

Dr Ross Calopedos

  • Doctor of Medicine, Bachelor of Medical Studies (University of New South Wales)

  • Master of Surgery – Urology (University of Sydney)

  • Fellow of the Australasian College of Surgeons

  • Full Member of the Urological Association of Australia and New Zealand

  • ECFMG Certification

  • Urological Ultrasound (Level II Certification)

  • Advanced Diploma in Spanish (DELE B2)

Qualifications

Areas of Expertise

Dr Ross’ practice focus includes:

  • Erectile Dysfunction: Comprehensive care, including penile implant surgery, penile Doppler ultrasound, and regenerative therapies.

  • Peyronie’s Disease: Personalised treatments, from conservative options to complex surgical corrections.

  • Prostate Cancer Survivorship: Holistic care to support men recovering from cancer treatments.

  • Functional and Cosmetic Urology: Including penile enhancement (UroFill®).

  • Minimally Invasive Urology: Advanced therapies for BPH, kidney stones, and bladder conditions.

Commitment to Australian Men

As an active member of USANZ, AUA, and SMSNA, Dr Ross is committed to advancing men’s health care in Australia. He frequently presents at international conferences and incorporates the latest research into his practice, ensuring his patients benefit from the most effective and innovative treatments available.

Leading Research and Innovation

Dr Ross is an award-winning researcher, recognised globally for his contributions to urology and sexual medicine.

In 2023, he received the SMSNA Research Award for his groundbreaking study on the penile suspensory ligament (PSL), which reshaped understanding of its role in surgical procedures. His work highlighted the biomechanical risks of PSL division, such as instability, pain, and sexual dysfunction, advocating for safer and more effective approaches. He has published extensively on topics including:

  • Prostate cancer survivorship

  • Penile implant surgery

  • Sexual health and andrology

  • Minimally invasive urological surgery

  • Medical Leadership and Training

Dr Ross Calopedos

Awards & Recognition

  • SMSNA Research Prize (2023)

  • Karl Storz IRCAD Grant (2020)

  • ANZUP Bayer Travel Fellowship (2017)

  • ANZUP ‘Best of the Best Trainee Award’ (2015)

Research

Dr. Ross is deeply committed to research and innovation in urology and men’s health.

He has presented his findings at national and international scientific conferences and published extensively in peer-reviewed medical journals. By staying at the forefront of medical advancements, Dr. Ross ensures his patients benefit from the latest knowledge and the most effective, evidence-based treatments, leading to optimal outcomes.

    1. Liu W, Calopedos R, Blecher G, Love C. Penile suspensory ligament: anatomy, function, and clinical perspectives of its repair. J Sex Med. 2025 Jan 3;22(1):175-183.

    2. Combes AD, Palma CA, Calopedos R, Wen L, Woo H, Fulham M, Leslie S. PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer. Diagnostics (Basel). 2022 Oct 26;12(11):2594.

    3. Ealing I, Calopedos R, Basto M, Palma C, Boulas J. Anatrophic nephrolithotomy and pyelolithotomy for dual staghorn calculi in bifid collecting system. J Surg Case Rep. 2022 Nov 26;2022(11): rjac547.

    4. Kwok M, Shugg N, Siriwardana A, Calopedos R, Richards K, Bandi S, Hempenstall J, Rashid P, Desai D. Prevalence and sequelae of penile lichen sclerosus in males presenting for circumcision in regional Australia: a multicentre retrospective cohort study. Transl Androl Urol. 2022 Jun;11(6):780-785.

    5. Yeung H, Sean S, Calopedos R, Woo H. Alfuzosin and Its Effect on Ejaculatory Dysfunction: A Systematic Review. World J Mens Health. 2021 Apr; 39(2):186-194.

    6. Calopedos R, Bang A, Baade P, Xue Q, Ruthven S, Patel MI, Smith D. Patterns of prostate-specific antigen testing by remoteness of residence and socioeconomic status: An Australian population-based study. Aust J Rural Health. 2019 Jun;27(3):216-223.

    7. Imran A, Calopedos R, Habashy D, Rashid P. Acknowledging and Addressing Surgeon Burnout. ANZ J Surg. 2018 Nov; 88(11):1100-1101.

    8. Calopedos R, Cachalia T, Arnold R, Sulaiman B. A fatal case of Primary Anal Melanoma in a Patient with Diagnosed Haemorrhoids. Int J Surg Res Pract 2018, 5: 073.

    9. Rashid P, Habashy D, Calopedos R. Trainees at risk: the need for support and compassion. ANZ J Surg. 2018 Nov; 88(11): 1106-1107.

    10. Smith DP, Calopedos R, Bang A, Yu XQ, Egger S, Chambers S, O'Connell DL. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data. PLoS One. 2018 Jun 13;13(6): e0198679.

    11. Naspro R, Lerner LB, Rossini R, Manica M, Woo HH, Calopedos R, Cracco CM, Scoffone CM, Herrmann TR, de la Rosette JJ, Cornu JN, DA Pozzo LF. Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: where do we stand with current literature? Minerva Urol Nefrol. 2018 Apr;70(2):126-136.

    12. Egger SJ, Calopedos R, O'Connell DL, Chambers SK, Woo HH, Smith DP. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer. Eur Urol. 2018 Jun;73(6):859-867.

    13. Calopedos R, Garcia C, Rashid P, Murphy DG, Lawrentschuk N, Woo HH.  Citation indices for social media articles in urology. BJU Int. 2017 May;119 Suppl 5:47-52.

    14. Calopedos R, Asher R, Chalasani V, Emmett L, Woo H. Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):352-360.

    15. March B, Calopedos R, Latif E, Ouyang R. Ureteric obstruction from malignant melanoma in both right double moiety and left single moiety ureters. Urology. 2017 May; 103: e7-e8.

    16. Calopedos R, March B, Latif B, Shin B, Chennapragada S, Ruthven S. Malignant masquerade: a rare case of urothelial carcinoma with squamous differentiation invading into the renal vein. ANZ J Surg. 2018 Dec;88(12):E845-E846.

    17. Louie-Johnsun MW, Handmer MM, Calopedos R, Chabert C, Cohen RJ, Gianduzzo TR, Kearns PA, Moon DA, Ooi J, Shannon T, Sofield D, Tan AH. The Australian laparoscopic non robotic radical prostatectomy experience - analysis of 2943 cases. BJU Int. 2016 Oct;118 Suppl 3:43-48.

    18. Calopedos R, Bang A, Patel M, Smith D. Patterns and outcomes of bladder cancer in New South Wales: A population-wide study of linked data. Asia-Pacific Journal of Clinical Oncology, 2015: 11, 25.

    19. Pudipeddi A, Calopedos R, Grabs A, Fenton-Lee D, Gett R. Duodenal Obstruction from a Secondary Aortoduodenal Fistula. ANZ J Surg. 2016 Jul;86(7-8):616.

    1. A Suarez-sarmiento Jr., P Perito, R Calopedos, M Brennan, B Dinerman, (021) POST-IPP ENHANCEMENT USING UROFILL® TECHNIQUE – SAFETY AND FEASIBILITY, The Journal of Sexual Medicine, Volume 21, Issue Supplement_7, December 2024, qdae167.019

    2. A Suarez-sarmiento Jr., P Perito, C Lemos, M Tulio Cavalcanti, G Veber, T Mierzwa, D Mauad, B Dinerman, M Brennan, R Calopedos, (020) PENILE HYALURONIC ACID INJECTIONS USING UROFILL TECHNIQUE: COMPLICATIONS AND THEIR MANAGEMENT, The Journal of Sexual Medicine, Volume 21, Issue Supplement_7, December 2024, qdae167.018

    3. R Calopedos, A Suarez-Sarmiento, P Perito, (168) SPURIOUS SPOUT: ANTIMICROBIAL PRACTICES DURING IPP INSERTION – SINGLE CENTER EXPERIENCE, The Journal of Sexual Medicine, Volume 21, Issue Supplement_7, December 2024, qdae167.165

    4. R Calopedos, A Suarez-Sarmiento, P Perito, (232) AGGRESSIVE REHABILITATION POST-IPP EXCHANGE: WE BLEW A GASKET, The Journal of Sexual Medicine, Volume 21, Issue Supplement_7, December 2024, qdae167.226

    5. Suarez-sarmiento Jr. A, Perito P, Lemos C, Tulio Cavalcanti M, Veber G, Mierzwa T, Mauad D, Dinerman B, Brennan M, Calopedos R. “Inyecciones de Ácido Hialurónico en el Pene Usando la Técnica UroFill: Complicaciones y su Manejo” 25Th Annual Fall Scientific Meeting of SMSNA, 2024.

    6. Suarez-sarmiento Jr. A, Perito P, Calopedos R, Brennan M, Dinerman B. Optimización del Implante de Pene Mediante la Técnica UroFill®. 25Th Annual Fall Scientific Meeting of SMSNA, 2024.

    7. Calopedos R, Suarez-Sarmiento A, Perito P. “Rehabilitación Agresiva después del Intercambio de Implante de Pene: Hemos Excedido los Límites.” 25Th Annual Fall Scientific Meeting of SMSNA, 2024.

    8. Calopedos R, Suarez-Sarmiento A, Perito P. “Prácticas Antimicrobianas Durante la Inserción de IPP – Experiencia de Centro Único.” 25Th Annual Fall Scientific Meeting of SMSNA, 2024.

    9. Perito P, Calopedos R, Suarez-Sarmiento A. “The State of Male Genital Cosmetics. What is ours?” 25thWorld Meeting on Sexual Medicine: Joint ISSM / SLAMS Scientific Meeting, 2024

    10. Calopedos R, Testa G, Deva A. Tensile Contention: A Novel Reconstructive Technique for Unstable Erections Secondary to Penile Suspensory Ligament (PSL) Deficiency. The Journal of Sexual Medicine, Volume 21, Issue Supplement_1, February 2024.

    11. Calopedos R, Rashid P, Zhang M. Destabilising Evidence: A Micro-Anatomical Investigation of Penile Suspensory Ligaments (PSL) Using Epoxy Sheet Plastination and Confocal Microscopy. The Journal of Sexual Medicine, Volume 21, Issue Supplement_1, February 2024.

    12. Calopedos R, Khalafalla K, Mahdi M, Slovacek H, Wang R. Reduced Glans Engorgement After Inflatable Penile Prosthesis – A Scoping Review of Factors Involved and Management Strategies. The Journal of Sexual Medicine, Volume 21, Issue Supplement_1, February 2024.

    13. Calopedos R, Khalafalla K, Pham R, Wang R. Manhandling: Post-IPP Mechanical Therapy – A Scoping Review. The Journal of Sexual Medicine, Volume 21, Issue Supplement_1, February 2024.

    14. Khalafalla K, Calopedos R, Mehr J, Wang R. Corporal Tissue Ingrowth: A Rare but Operable Challenge in Revision Surgery for Inflatable Penile Prosthesis. The Journal of Sexual Medicine, Volume 21, Issue Supplement_2, March 2024.

    15. Calopedos R, Bariol S. Compatibility of Ureteroscopic Tools and their Impact on Maximum Scope Deflection: The Stiffness Coefficient. NSW Section, USANZ, 2019

    16. Lutetium-177 labelled Prostate-Specific Membrane Antigen (PSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A Systematic Review and Meta-analysis. Calopedos R, Asher R, Chalasani V, Emmett L, Woo H. UAA 2017 & ANZUP AGM 2017

    17. Calopedos R, Smith D, Bang A, Yu XQ, Egger S, Chambers S, O’Connell D. Increased risk of suicide in NSW men with prostate cancer: analysis of linked population-wide data. ANZUP AGM 2017.

    18. Wood D, Sanderson B, Amith I, Sheehan P, Calopedos R, McKinnon R, Reeves D. Application of lean six sigma principles can improve venous thromboembolism prevention. Ko Awatea Excellence in Health Improvement Award, 2016.

    19. Patterns and outcomes of bladder cancer in New South Wales: A population-wide study of linked data. Calopedos R, Bang A, Patel M, Smith D. ANZUP AGM, 2015

    20. The Australian laparoscopic non-robotic radical prostatectomy experience – Analysis of 2943 cases. Louie-Johnsun, MW., Handmer, MM., Calopedos, R., Chabert, C., Cohen, RJ., Gianduzzo, TRJ., Gianduzzo,TRJ., Kearns, PA., Moon, DA., Ooi, J., Shannon, T., Sofield, D., Tan, AHH. ANZUP AGM, 2015

    21. Patterns of prostate specific antigen testing and prostate biopsy by region and socio-economic status: An Australian population-based study. Calopedos R, Bang A, Smith D. USANZ Annual Meeting, 2015

    22. Calopedos R, Bang A, Patel M, Smith P. Patterns of Surgical Care of Prostate Cancer in New South Wales: A Population-based descriptive study. NSW Section Meeting, USANZ, 2015

    23. Calopedos R, Keller A, Handmer M, Chabert C, Cohen R, Gianduzzo T, Kearns P, Ooi J, Shannon T, Sofield D, Tan A, Louie-Johnsun M. Should we be investing in the training of laparoscopic radical prostatectomy in Australia? A Cost Analysis Based on the Australian Experience of 2735 cases. NSW Section Meeting, USANZ, 2015 & ANZUP AGM, 2015.

    24. Louie-Johnsun MW, Handmer MM, Calopedos R, Chabert C, Cohen RJ, Gianduzzo TRJ, Kearns PA, Moon DA, Ooi J, Shannon T, Sofield D, Tan AHH. Is there a significant learning curve of Fellowship-trained Australian laparoscopic radical prostatectomists? Comparison of first 100 to second 100 cases. ANZUP AGM, 2015

    25. Calopedos R. VTE Risk Assessment Tool Roll-out: Presentation at NUM meeting, Surgical Heads of Department meeting, Wyong Hospital Grand Rounds, 2015

    26. Calopedos R. Quality and Safety on the Central Coast: Presentation to new JMOs about role of Quality assurance in the medical profession and the scope for JMO involvement in CCLHD, 2015

    27. Calopedos R. LEVEL UP Feedback Tool: Project presentation from HETI’s LEAP program, 2015.

Additional Training

(after Urology Specialisation)

  • Further expertise in the minimally invasive treatment of renal stone disease, bladder conditions, enlarged prostate, and prostate cancer. This included proficiency in robotic-assisted and laparoscopic surgery, laser stone surgery utilising Holmium and Thulium laser technologies, and cutting-edge prostate biopsy techniques, such as robotic-targeted MRI fusion transperineal prostate biopsy.

    This training was complemented with a rotation through Kuala Lumpur general hospital, where he undertook advanced training in PCNL (Percutaneous Nephrolithotomy). The high prevalence of stone disease in Malaysia has fostered advanced techniques that are less common in Australia, providing Dr Ross with unique skills to offer more effective and comprehensive treatments for complex cases.

  • Dr Ross pursued an advanced global clinical fellowship to deepen his expertise in prosthetic urology, sexual health, and penile surgery. Recognising the value of learning from diverse international leaders, he completed multiple specialised fellowship programs at some of the world’s most renowned centres of excellence. These programs provided unparalleled exposure to the latest treatments and surgical techniques for conditions such as erectile dysfunction, Peyronie’s disease, low testosterone, penile implant surgery, and other aspects of male sexual dysfunction.

  • In Spain, Dr Ross Calopedos had the privilege of training at the prestigious Lyx Institute in Madrid, a leading multidisciplinary centre for urology and Europe’s highest-volume referral centre for Peyronie’s disease. During his time there, he gained extensive hands-on experience in managing Peyronie’s disease, including conservative treatments such as oral medications and physical therapy, as well as intralesional therapies.

    He further refined his surgical skills, performing a variety of corrective procedures, including Plication, Nesbit, and Yachia techniques, penile implants, and complex grafting surgeries using autologous rectus fascia rather than synthetic graft materials. His experience also encompassed the placement of both penoscrotal and infrapubic inflatable penile prostheses (IPP) and malleable penile prostheses (MPP).

    Under the guidance of Dr Eugenio Cerezo, the world’s foremost expert in penile duplex ultrasound, Dr Ross developed a profound understanding of penile anatomy and function. This training allowed him to accurately diagnose and manage complex cases of erectile dysfunction with precision and confidence.

    Additionally, under the mentorship of Dr. Ignacio Sola, Dr Ross expanded his proficiency in minimally invasive treatments for benign prostatic hyperplasia (BPH). He mastered Holmium Laser Enucleation of the Prostate (HoLEP) and the newer Minimally Invasive Laser Enucleation of the Prostate (MiLEP).

  • In London, Dr Ross worked closely with Professor David Ralph, a globally recognised leader in erectile dysfunction. This focused training provided exposure to a wide range of advanced reconstructive procedures, including:

    • Management of severe Peyronie’s disease: Plaque excision and grafting without a penile tourniquet, ventral corporoplasty, and penile disassembly techniques.

    • Genital Reconstructive surgery: Genital lymphedema repair, buried penis reconstruction, and treatments for post-prostatectomy climacturia, such as the mini-Jupette procedure.

    • Cosmetic and functional procedures: Suprapubic lipectomy, abdominoplasty, scrotoplasty, phallopexy, and specialised scrotectomy techniques.

  • Dr Ross trained under Professor Koenraad van Renterghem, a globally respected innovator and leader in urological prosthetics and men’s health. This fellowship provided invaluable hands-on experience in advanced penile implant techniques, particularly for complex cases involving multiple urological conditions. This training provided exposure to cutting-edge procedures, including:

    • Simultaneous double implant surgery: For men with concurrent erectile dysfunction and urinary incontinence, particularly in post-prostate cancer patients, both an inflatable penile prosthesis (IPP) and an artificial urinary sphincter (AUS) can be placed through a single incision. This technique, pioneered by Professor van Renterghem, reduces the number of surgical incisions from three to one, minimising time under general anaesthesia and recovery times.

    • Advanced penile prosthesis techniques: Focused on Peyronie’s correction, penoscrotal penile prosthesis insertion, and alternative reservoir placements.

  • During his training with Dr Dean Elterman, a renowned expert in minimally invasive therapies for benign prostatic hyperplasia (BPH), Dr Ross gained hands-on experience with a range of cutting-edge treatments, including:

    • Aquablation: Robotic-assisted water jet therapy for precise removal of prostate tissue.

    • Rezum: Water vapor therapy offering effective symptom relief with minimal invasiveness.

    • Optilume BPH Catheter System: A novel approach using drug-coated balloon dilation to alleviate obstruction.

    • UroLift: Prostatic urethral lift to open the urinary pathway while preserving sexual function.

    • iTind: Temporary Nitinol Device implantation to reshape the prostatic urethra and relieve symptoms.

    These advanced, minimally invasive treatments are designed to provide effective symptom relief while preserving sexual function, offering ideal solutions for men seeking alternatives to traditional surgery.

  • Dr Ross trained under Dr Paul Perito, the world’s highest-volume penile implant surgeon, global leader and renowned innovator in men’s health, mastering the advanced minimally invasive infrapubic approach for penile prosthesis insertion. This technique, pioneered by Dr Perito, significantly reduces recovery time while optimising patient outcomes.

    During his time at the Perito Clinic in Miami, a world-class centre for men’s health, Dr Ross gained hands-on experience in:

    1. Penile Prosthesis Surgery: Performing over 200 penile implant procedures using the minimally invasive infrapubic technique.

    2. Reservoir Placement Techniques: Including the innovative midline technique, enabling safe reservoir placement in men regardless of surgical history, through the same 2.5-3 cm incision.

    3. Complex and Non-Standard Cases:

    • Salvage malleable penile prosthesis placement following infection

    • Glans hypermobility correction.

    • Obturator fenestration for corporal fibrosis.

    • Endocavernotomy for erectile body stenosis.

    • The Perito "Scratch" technique for minimally invasive correction of penile curvature and deformities. 

    Dr. Ross also became Australia’s leading expert in the UroFill® penile girth enhancement technique, a non-surgical aesthetic solution for men seeking enhancement without compromising function. This innovative procedure allows for safe, effective, and minimally invasive penile girth augmentation without general anaesthesia.

    By mastering these advanced surgical and non-surgical techniques, Dr Ross offers men in Australia a unique approach to urological care. His expertise addresses a wide range of urological and men’s health concerns, from erectile dysfunction and Peyronie’s disease to aesthetic and functional enhancements, ensuring personalised care with precision and compassion.

A personlised approach to care

Dr Ross believes that every patient deserves tailored, compassionate care. By combining advanced diagnostics, minimally invasive techniques and his global expertise, he empowers men to take control of their health and regain their confidence.

Contact us for more information or to book a confidential consultation today.

Frequently Asked Questions (FAQ)

  • A urologist is a specialist surgeon who diagnoses and treats anyone with a problem with their adrenals, kidneys, ureters, bladder, prostate, urethra and any of the male reproductive organs. This includes common conditions like kidneys stones, prostate problems, urinary tract infections and erectile dysfunction.

  • Becoming a urologist in Australia involves a rigorous educational and clinical pathway. First, aspiring doctors complete a 5-6 year medical degree, then work as junior doctors in hospitals for at least 2 years, gaining essential clinical experience in all aspects of inpatient care. Next, candidates apply to a highly competitive surgical specialty program, where applications from doctors across Australia and New Zealand are evaluated based on research, tertiary education, clinical performance, referee reports and interviews. The urology training program, jointly overseen by the Urological Society of Australia and New Zealand and the Royal Australasian College of Surgeons, requires an additional 5-6 years of practical training, comprehensive examinations, and rigorous performance assessments. This extensive training ensures that specialists are fully equipped to deliver high-quality urological care. For those seeking further expertise, additional subspecialisation options are available.

  • Yes, urologists treat female patients. While urology is often associated with male reproductive health, urologists also diagnose and manage conditions affecting the female urinary tract. This includes urinary tract infections (UTIs), overactive bladder, incontinence, pelvic pain, and other disorders.

  • Although both specialists address aspects of pelvic health, their training, focus, and the conditions they treat differ significantly. Gynaecologists focus on the female reproductive system, managing menstrual health, pregnancy, childbirth, and disorders of the uterus, ovaries, and other reproductive organs. Urologists are specialists of the female bladder, urethra and upper urinary tract.

  • While both specialists focus on kidney health, urologists are surgeons who treat issues of the urinary tract, often using surgical procedures when necessary. Nephrologists, on the other hand, focus on the medical management of kidney diseases and systemic conditions affecting kidney function.